A new chink in cancer's armor: Unleashing cell death by selective PP5 inhibition.

Patricija van Oosten-Hawle
Author Information
  1. Patricija van Oosten-Hawle: Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA. Electronic address: pvanoost@charlotte.edu.

Abstract

Serine/threonine protein phosphatases play a significant role in the survival and propagation of multiple cancers. In this issue of Cell Chemical Biology, Ahanin et al. demonstrate that protein phosphatase 5 (PP5) dephosphorylates and inactivates the cell death effector protein FADD independently of Hsp90, and they identify a selective PP5 inhibitor as a new therapeutic strategy for renal cancer.

MeSH Term

Phosphoprotein Phosphatases
Nuclear Proteins
Cell Death
Neoplasms

Chemicals

protein phosphatase 5
tissue-factor-pathway inhibitor 2
Phosphoprotein Phosphatases
Nuclear Proteins

Word Cloud

Similar Articles

Cited By